Product Code: RP-ID-10012800 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10012800
Market Overview:
Global In Situ Hybridization (ISH) Market Size Study, By Technology (CISH, and FISH), By Probe Type (RNA, and DNA), By Product (Software, Probes & Kits, Services, and Instruments), By Application, By End-Use, and By Regional Forecasts, 2018-2025
Global In Situ Hybridization (ISH) Market to reach USD 1.91 billion by 2025.
Global In Situ Hybridization (ISH) Market valued approximately USD 970.80 million in 2016 is forecasted to grow with a healthy growth rate of more than 7.81% over the forecast period 2018-2025. The major factors predicted to augment the market are growing demand for molecular diagnostic tools and coupled with the need for rapid diagnostic techniques and a rise in the incidence of chronic diseases. In situ hybridization (ISH) is a type of hybridization that uses a labeled complementary RNA, DNA or modified nucleic acids strand (i.e., probe) to localize a specific RNA or DNA sequence in a portion or section of tissue, or, if the tissue is small enough (e.g., plant seeds), in the entire tissue (whole mount ISH), in cells, and in circulating tumor cells (CTCs).
The regional analysis of Global In Situ Hybridization (ISH) Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world in terms of market share. Whereas, owing to the countries such as China, Japan, and India, Asia Pacific region is also expected to exhibit higher growth rate / CAGR over the forecast period 2018-2025.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Technology:
 Chromogenic In-Situ Hybridization (CISH)
 Fluorescent In-Situ Hybridization (FISH)
By Probe Type:
 RNA
 DNA
By Product:
 Software
 Probes & Kits
 Services
 Instruments
 Others
By Application:
 Cytogenesis
 Infectious Diseases
 Cancer
 Developmental Biology
 Others
By End-Use:
 Academic Institutions
 Research & Diagnostic Laboratories
 CROs
 Others
By Regions:
 North America
o U.S.
o Canada
 Europe
o UK
o Germany
 Asia Pacific
o China
o India
o Japan
 Latin America
o Brazil
o Mexico
 Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2015, 2016
Base year – 2017
Forecast period – 2018 to 2025
The industry is seeming to be fairly competitive. Some of the leading market players include BIOVIEW, Thermo Fisher Scientific, Merck KGaA, Leica Biosystems Nussloch GmbH, Agilent Technologies; Bio-Rad Laboratories, Inc., PerkinElmer, Inc., Advanced Cell Diagnostics, Inc., Oxford Gene Technology, NeoGenomics Laboratories, Inc., and so on. The fierce competitiveness has made these players spend in product developments to improve the customer’s requirements.
Target Audience of the In Situ Hybridization (ISH) Market Study:
 Key Consulting Companies & Advisors
 Large, medium-sized, and small enterprises
 Venture capitalists
 Value-Added Resellers (VARs)
 Third-party knowledge providers
 Investment bankers
 Investors
Thermo Fisher Scientific
Merck KGaA
Leica Biosystems Nussloch GmbH
Agilent Technologies
PerkinElmer, Inc.
Advanced Cell Diagnostics, Inc.
Oxford Gene Technology
NeoGenomics Laboratories, Inc.,
Related Reports
Proof of Quality & Reliability
